• Join our community!

    Do you have questions about celiac disease or the gluten-free diet?

  • Ads by Google:
     




    Get email alerts Subscribe to Celiac.com's FREE weekly eNewsletter

    Ads by Google:



       Get email alertsSubscribe to Celiac.com's FREE weekly eNewsletter

  • Member Statistics

    77,651
    Total Members
    3,093
    Most Online
    Kitty11
    Newest Member
    Kitty11
    Joined
  • 0

    Strong Compliance with Gluten-Free Standards Mean Consumers Can Buy With Confidence


    Jefferson Adams


    • FDA shows overwhelming compliance with gluten-free labeling rules.


    Celiac.com 11/01/2017 - Recent product testing by the FDA shows overwhelming compliance with FDA's requirement that foods labeled "gluten-free" have less than 20 parts per million detectable gluten.


    Ads by Google:




    ARTICLE CONTINUES BELOW ADS
    Ads by Google:



    According to the FDA, more than 99.5 percent of "gluten-free" food products met the agency's gluten-free standard, according to Carol D'Lima, a food technologist in FDA's Office of Nutrition and Food Labeling.

    The FDA collected and analyzed 702 samples from more than 250 products labeled "gluten free." So far, D'Lima noted, only one product labeled as gluten-free tested positive for gluten levels above 20 ppm.

    The FDA does not name the products that were tested, but does note that the failed product was "recalled and subsequent sampling by the FDA did not find levels of gluten that violated the regulation."

    Also, the FDA testing very likely includes products by major manufacturers. That's likely good news for manufacturers like General Mills, which made news recently when they announced that they will voluntarily remove the "Gluten-Free" label from their Cheerios products in Canada.

    The company says that it did not make the move due to any concerns about gluten levels, but due to a technicality over oat testing protocols under which oat products can be labeled "Gluten-Free."

    A statement from the company's website reads in part: "Each serving of Cheerios products in Canada are gluten free, as defined by the current regulatory standard of containing less than 20 ppm of gluten. General Mills Canada has made the decision to voluntarily remove the gluten-free label from our Cheerios products in Canada until Health Canada and The Canadian Food Inspection Agency (CFIA) publish a consistent testing protocol for products containing oats. At this time the product is not changing, just the label on the box."

    Absent any product recalls in the face of the FDA product testing, it's safe to assume that the consumers can take General Mills and other companies at their word, and trust that products labeled gluten-free meet FDA gluten-free standards, and are safe for people with celiac disease.

    Such high compliance levels by food manufacturers mean that the FDA may now put more of their resources into other enforcement measure, including ensuring that the supply chain remains free from cross-contamination.

    Even in the face of such encouraging test results, look for the FDA to remain diligent in validating "Gluten-Free" and other labeling claims. The FDA maintains "an ongoing compliance program," says D'Lima. Under that program, field staff in FDA district offices conduct inspections that include products labeled as gluten-free.

    If any products are found to be out of compliance for gluten standards, the FDA notifies the company to make appropriate corrections, and works with the company to recall any mislabeled products on the market.

    Source:

    0


    User Feedback

    Recommended Comments

    There are no comments to display.



    Your content will need to be approved by a moderator

    Guest
    You are commenting as a guest. If you have an account, please sign in.
    Add a comment...

    ×   Pasted as rich text.   Paste as plain text instead

      Only 75 emoji are allowed.

    ×   Your link has been automatically embedded.   Display as a link instead

    ×   Your previous content has been restored.   Clear editor

    ×   You cannot paste images directly. Upload or insert images from URL.


  • Ads by Google:

  • About Me

    Jefferson Adams is a freelance writer living in San Francisco. He has covered Health News for Examiner.com, and provided health and medical content for Sharecare.com. His work has appeared in Antioch Review, Blue Mesa Review, CALIBAN, Hayden's Ferry Review, Huffington Post, the Mississippi Review, and Slate, among others.

  • Popular Contributors

  • Ads by Google:

  • Who's Online   14 Members, 0 Anonymous, 634 Guests (See full list)

  • Related Articles

    Jefferson Adams
    Celiac.com 03/18/2015 - A man who suffers from celiac disease has sued the FDA for allowing gluten to be used as a coating on prescription drug and over-the-counter medicine capsules.
    Remember, people with celiac disease can suffer intestinal damage when they consume gluten. This can damage can lead to neurological, among other disorders.
    The man, Michael Weber, was taking a generic drug seven years ago, and developed side effects consistent with ingesting gluten.
    Weber says he was unable to determine the drug’s gluten status through his pharmacist, and
    Weber went on to petition the FDA to either eliminate wheat gluten in medicines or require new labeling on drugs containing the protein.
    In 2011, the FDA sought public comments about the issue. In 2014, the FDA issued gluten-free definitions and labeling standards for commercial foods, but has failed to act on drugs. So Weber has now filed a lawsuit to demand the FDA do something. The complaint can be read here.
    This raises a couple of questions: Do people with celiac disease deserve to know if there is gluten in their medicine? Do they deserve access to medicines that are gluten-free? Should the FDA definitions and labeling standards also apply to drugs and medicines?

    Jefferson Adams
    Celiac.com 11/24/2016 - When Australia set it's gluten-content standards at zero ppm for gluten-free labeling, many people in the gluten-free community hailed the action as revolutionary for people with celiac disease or gluten-sensitivity.
    Sensitivity to gluten varies among celiac patients, so, in theory, restricting levels in food to under one part per million (ppm) would protect the maximum number of patients.
    International gluten-free standards require that foods labelled "gluten-free" (gluten-free) contain less than 20 ppm gluten. In Australia and New Zealand, however, a "no detectable gluten" standard applies.
    Now, a pair of researchers say product testing shows that 14% of imported products were non-compliant with the current Australian standard, but none contained more than 1.1 ppm gluten.
    Geoffrey M Forbes and Kenneth Dods are calling those standards "not practical or reasonable," and urging authorities revise the current Australian gluten-free standard of "no detectable gluten" to "≤ 1 ppm."
    Read the full story at: Med J Aust 2016; 205 (7): 316. doi: 10.5694/mja16.00485

    Jefferson Adams
    Celiac.com 07/10/2017 - For anyone with celiac disease or gluten intolerance who was wondering how well food manufacturers are complying with FDA standard for gluten-free labeling, or wondering exactly how gluten-free is my gluten-free food, some early answers are in, and the news looks good.
    A recent report by the agency indicates that the vast majority of food manufacturers are getting it right, and, correcting where they do get it wrong.
    The FDA's final rule for compliance in gluten-free labeling was August 5, 2014. To gauge compliance in gluten-free food labeling, the agency conducted a sampling assignment of products labeled "gluten free" from July 2015 to August 2016.
    The compliance testing is an important part of the FDA's mission to ensure that products labeled on or after the compliance date are properly labeled as "gluten-free."
    In all, the agency's team analyzed more than 250 types of products, and tested 702 individual samples in the categories of cereals, grain bars, and flours.
    Their complete survey showed that just five samples from one product source contained gluten in excess of the regulatory limit of 20 parts per million (ppm). That left the overall gluten-free product-based compliance rate above 99.5 percent.
    The good news here is that producers major gluten-free food products are doing a very good job of following FDA labeling standards. Also, the manufacturer of the samples that showed gluten levels above 20 ppm carried out a voluntary recall, conducted an extensive root cause analysis, and immediately implemented additional corrective actions to prevent recurrence.
    Follow-up testing by the FDA showed acceptable levels of gluten.
    This is the first hard data the FDA has gathered regarding compliance with gluten-free labeling standards. To see such high levels of compliance and responsiveness by manufacturers is encouraging.
    Read the Analytical Results of FY2015/16 Gluten-Free Food Product Sampling. SOURCE: FDA.gov

    Jefferson Adams
    Celiac.com 07/27/2017 - The Gluten Free Certification Organization (GFCO) was founded in 2005 by the Gluten Intolerance Group of North America (GIG) to offer independent certification to manufacturers of gluten-free products.
    GFCO certification is accredited to ISO 17065, and assures consumers with gluten sensitivities that a product meets the strict gluten-free standards. In most cases, GFCO standards exceed those of Codex, US, Canada, the EU and many other country standards for gluten-free products. For example, the GFCO guarantees that all products with its logo contain 10ppm or less of gluten.
    The GFCO also confirms the validity of a manufacturer's gluten-free processes, and substantiates claims about the products.
    To ensure quality of Gluten-Free Certification Organization (GFCO) standards, the GIG has retained New Jersey-based certification company SGS, whose inspection, verification, testing and certification services are globally respected for quality and integrity.
    According to SGS, the GFCO audits will either be combined with SGS' Food Safety certification audits, or conducted as a standalone service.
    Those seeking rigid gluten-free standards can look for the GFCO label on products labeled "gluten-free."
    Source:
    bakeryandsnacks.com

  • Recent Articles

    Jefferson Adams
    Celiac.com 06/21/2018 - Would you buy a house advertised as ‘gluten-free’? Yes, there really is such a house for sale. 
    It seems a Phoenix realtor Mike D’Elena is hoping that his trendy claim will catch the eye of a buyer hungry to avoid gluten, or, at least one with a sense of humor. D’Elena said he crafted the ads as a way to “be funny and to draw attention.” The idea, D’Elena said, is to “make it memorable.” 
    Though D’Elena’s marketing seeks to capitalizes on the gluten-free trend, he knows Celiac disease is a serious health issue for some people. “[W]e’re not here to offend anybody….this is just something we're just trying to do to draw attention and do what's best for our clients," he said. 
    Still, the signs seem to be working. D'elena had fielded six offers within a few days of listing the west Phoenix home.
    "Buying can sometimes be the most stressful thing you do in your entire life so why not have some fun with it," he said. 
    What do you think? Clever? Funny?
    Read more at Arizonafamily.com.

    Advertising Banner-Ads
    Bakery On Main started in the small bakery of a natural foods market on Main Street in Glastonbury, Connecticut. Founder Michael Smulders listened when his customers with Celiac Disease would mention the lack of good tasting, gluten-free options available to them. Upon learning this, he believed that nobody should have to suffer due to any kind of food allergy or dietary need. From then on, his mission became creating delicious and fearlessly unique gluten-free products that were clean and great tasting, while still being safe for his Celiac customers!
    Premium ingredients, bakeshop delicious recipes, and happy customers were our inspiration from the beginning— and are still the cornerstones of Bakery On Main today. We are a fiercely ethical company that believes in integrity and feels that happiness and wholesome, great tasting food should be harmonious. We strive for that in everything we bake in our dedicated gluten-free facility that is GFCO Certified and SQF Level 3 Certified. We use only natural, NON-GMO Project Verified ingredients and all of our products are certified Kosher Parve, dairy and casein free, and we have recently introduced certified Organic items as well! 
    Our passion is to bake the very best products while bringing happiness to our customers, each other, and all those we meet!
    We are available during normal business hours at: 1-888-533-8118 EST.
    To learn more about us at: visit our site.

    Jefferson Adams
    Celiac.com 06/20/2018 - Currently, the only way to manage celiac disease is to eliminate gluten from the diet. That could be set to change as clinical trials begin in Australia for a new vaccine that aims to switch off the immune response to gluten. 
    The trials are set to begin at Australia’s University of the Sunshine Coast Clinical Trials Centre. The vaccine is designed to allow people with celiac disease to consume gluten with no adverse effects. A successful vaccine could be the beginning of the end for the gluten-free diet as the only currently viable treatment for celiac disease. That could be a massive breakthrough for people with celiac disease.
    USC’s Clinical Trials Centre Director Lucas Litewka said trial participants would receive an injection of the vaccine twice a week for seven weeks. The trials will be conducted alongside gastroenterologist Dr. James Daveson, who called the vaccine “a very exciting potential new therapy that has been undergoing clinical trials for several years now.”
    Dr. Daveson said the investigational vaccine might potentially restore gluten tolerance to people with celiac disease.The trial is open to adults between the ages of 18 and 70 who have clinically diagnosed celiac disease, and have followed a strict gluten-free diet for at least 12 months. Anyone interested in participating can go to www.joinourtrials.com.
    Read more at the website for Australia’s University of the Sunshine Coast Clinical Trials Centre.

    Source:
    FoodProcessing.com.au

    Jefferson Adams
    Celiac.com 06/19/2018 - Could baking soda help reduce the inflammation and damage caused by autoimmune diseases like rheumatoid arthritis, and celiac disease? Scientists at the Medical College of Georgia at Augusta University say that a daily dose of baking soda may in fact help reduce inflammation and damage caused by autoimmune diseases like rheumatoid arthritis, and celiac disease.
    Those scientists recently gathered some of the first evidence to show that cheap, over-the-counter antacids can prompt the spleen to promote an anti-inflammatory environment that could be helpful in combating inflammatory disease.
    A type of cell called mesothelial cells line our body cavities, like the digestive tract. They have little fingers, called microvilli, that sense the environment, and warn the organs they cover that there is an invader and an immune response is needed.
    The team’s data shows that when rats or healthy people drink a solution of baking soda, the stomach makes more acid, which causes mesothelial cells on the outside of the spleen to tell the spleen to go easy on the immune response.  "It's most likely a hamburger not a bacterial infection," is basically the message, says Dr. Paul O'Connor, renal physiologist in the MCG Department of Physiology at Augusta University and the study's corresponding author.
    That message, which is transmitted with help from a chemical messenger called acetylcholine, seems to encourage the gut to shift against inflammation, say the scientists.
    In patients who drank water with baking soda for two weeks, immune cells called macrophages, shifted from primarily those that promote inflammation, called M1, to those that reduce it, called M2. "The shift from inflammatory to an anti-inflammatory profile is happening everywhere," O'Connor says. "We saw it in the kidneys, we saw it in the spleen, now we see it in the peripheral blood."
    O'Connor hopes drinking baking soda can one day produce similar results for people with autoimmune disease. "You are not really turning anything off or on, you are just pushing it toward one side by giving an anti-inflammatory stimulus," he says, in this case, away from harmful inflammation. "It's potentially a really safe way to treat inflammatory disease."
    The research was funded by the National Institutes of Health.
    Read more at: Sciencedaily.com

    Jefferson Adams
    Celiac.com 06/18/2018 - Celiac disease has been mainly associated with Caucasian populations in Northern Europe, and their descendants in other countries, but new scientific evidence is beginning to challenge that view. Still, the exact global prevalence of celiac disease remains unknown.  To get better data on that issue, a team of researchers recently conducted a comprehensive review and meta-analysis to get a reasonably accurate estimate the global prevalence of celiac disease. 
    The research team included P Singh, A Arora, TA Strand, DA Leffler, C Catassi, PH Green, CP Kelly, V Ahuja, and GK Makharia. They are variously affiliated with the Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Lady Hardinge Medical College, New Delhi, India; Innlandet Hospital Trust, Lillehammer, Norway; Centre for International Health, University of Bergen, Bergen, Norway; Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts; Gastroenterology Research and Development, Takeda Pharmaceuticals Inc, Cambridge, MA; Department of Pediatrics, Università Politecnica delle Marche, Ancona, Italy; Department of Medicine, Columbia University Medical Center, New York, New York; USA Celiac Disease Center, Columbia University Medical Center, New York, New York; and the Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India.
    For their review, the team searched Medline, PubMed, and EMBASE for the keywords ‘celiac disease,’ ‘celiac,’ ‘tissue transglutaminase antibody,’ ‘anti-endomysium antibody,’ ‘endomysial antibody,’ and ‘prevalence’ for studies published from January 1991 through March 2016. 
    The team cross-referenced each article with the words ‘Asia,’ ‘Europe,’ ‘Africa,’ ‘South America,’ ‘North America,’ and ‘Australia.’ They defined celiac diagnosis based on European Society of Pediatric Gastroenterology, Hepatology, and Nutrition guidelines. The team used 96 articles of 3,843 articles in their final analysis.
    Overall global prevalence of celiac disease was 1.4% in 275,818 individuals, based on positive blood tests for anti-tissue transglutaminase and/or anti-endomysial antibodies. The pooled global prevalence of biopsy-confirmed celiac disease was 0.7% in 138,792 individuals. That means that numerous people with celiac disease potentially remain undiagnosed.
    Rates of celiac disease were 0.4% in South America, 0.5% in Africa and North America, 0.6% in Asia, and 0.8% in Europe and Oceania; the prevalence was 0.6% in female vs 0.4% males. Celiac disease was significantly more common in children than adults.
    This systematic review and meta-analysis showed celiac disease to be reported worldwide. Blood test data shows celiac disease rate of 1.4%, while biopsy data shows 0.7%. The prevalence of celiac disease varies with sex, age, and location. 
    This review demonstrates a need for more comprehensive population-based studies of celiac disease in numerous countries.  The 1.4% rate indicates that there are 91.2 million people worldwide with celiac disease, and 3.9 million are in the U.S.A.
    Source:
    Clin Gastroenterol Hepatol. 2018 Jun;16(6):823-836.e2. doi: 10.1016/j.cgh.2017.06.037.